Ignite Creation Date:
2025-12-25 @ 12:03 AM
Ignite Modification Date:
2026-06-27 @ 11:03 PM
Study NCT ID:
NCT03246958
Status:
COMPLETED
Last Update Posted:
2025-06-19
First Post:
2017-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Nivolumab Plus Ipilimumab in Thyroid Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
17-255
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |